Does the achievement of an intermediate glycemic target reduce organ failure and mortality? A post hoc analysis of the Glucontrol trial

Journal of Critical Care

Volumn 29, Issue 3, 2014, Pages 374-379

  Penning, Sophie ^a   Chase, J Geoffrey ^b   Preiser, Jean Charles ^c   Pretty, Christopher G ^b   Signal, Matthew ^b   Mélot, Christian ^c   Desaive, Thomas ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF CANTERBURY   (New Zealand)

^c ERASME HOSPITAL   (Belgium)

Author keywords

Critical care; Critically ill patients; Glycemia; Intensive care; Mortality; Organ failure

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; DEATH; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; POST HOC ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; ACHIEVEMENT; ANALYSIS; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; MIDDLE AGED; MULTICENTER STUDY; ORGAN DYSFUNCTION SCORE; PROSPECTIVE STUDY; RISK;

ACHIEVEMENT; AGED; BLOOD GLUCOSE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; ODDS RATIO; ORGAN DYSFUNCTION SCORES; PROSPECTIVE STUDIES;

EID: 84899967500     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.01.013     Document Type: Article

References (22)

1. Sakr Y., Vincent J.-L., Ruokonen E., et al. Sepsis and organ system failure are major determinants of post-intensive care unit mortality. J Crit Care 2008, 23(4):475-483.
2. Vincent J.L., Moreno R., Takala J., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22(7):707-710.
3. Vincent J.L., de Mendonca A., Cantraine F., et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998, 26(11):1793-1800.
4. Vincent J.L. Organ dysfunction in patients with severe sepsis. Surg Infect (Larchmt) 2006, 7(Suppl 2):S69-S72.
5. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345(19):1359-1367.
6. Chase J.G., Shaw G., Le Compte A., et al. Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change. Crit Care 2008, vol. 12.
7. Mesotten D., Van den Berghe G. Clinical benefits of tight glycaemic control: focus on the intensive care unit. Best Pract Res 2009, 23(4):421-429.
8. Fahy B.G., Sheehy A.M., Coursin D.B. Glucose control in the intensive care unit. Crit Care Med 2009, 37(5):1769-1776.
9. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004, 79(8):992-1000.
10. Preiser J.C., Devos P., Ruiz-Santana S., et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009, 35(10):1738-1748.
11. Finfer S., Delaney A. Tight glycemic control in critically ill adults. JAMA 2008, 300(8):963-965.
12. Brunkhorst F.M., Engel C., Bloos F., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358(2):125-139.
13. Treggiari M.M., Karir V., Yanez N.D., et al. Intensive insulin therapy and mortality in critically ill patients. Crit Care 2008, 12(1):R29.
14. Griesdale D.E., de Souza R.J., van Dam R.M., et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009, 180(8):821-827.
15. Marik P.E., Preiser J.C. Toward understanding tight glycemic control in the ICU: a systematic review and meta-analysis. Chest 2010, 137(3):544-551.
16. Moghissi E.S., Korytkowski M.T., DiNardo M., et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract 2009, 15(4):353-369.
17. Krinsley J.S., Preiser J.C. Moving beyond tight glucose control to safe effective glucose control. Crit Care 2008, 12(3):149.
18. Chase J.G., Pretty C.G., Pfeifer L., et al. Organ failure and tight glycemic control in the SPRINT study. Crit Care 2010, 14(4):R154.
19. Ferreira F.L., Bota D.P., Bross A., et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001, 286(14):1754-1758.
20. Mackenzie I.M., Whitehouse T., Nightingale P.G. The metrics of glycaemic control in critical care. Intensive Care Med 2011, 37(3):435-443.
21. Krinsley J.S. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008, 36(11):3008-3013.
22. Krinsley J.S. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003, 78(12):1471-1478.